102 related articles for article (PubMed ID: 20456720)
1. Correlation between pruritus score and grossly visible erythema in dogs.
Hill P; Rybníček J; Lau-Gillard P
Vet Dermatol; 2010 Oct; 21(5):450-5. PubMed ID: 20456720
[TBL] [Abstract][Full Text] [Related]
2. Further validation of a pruritus severity scale for use in dogs.
Rybnícek J; Lau-Gillard PJ; Harvey R; Hill PB
Vet Dermatol; 2009 Apr; 20(2):115-22. PubMed ID: 19171021
[TBL] [Abstract][Full Text] [Related]
3. Repeatability and reproducibility of numerical rating scales and visual analogue scales for canine pruritus severity scoring.
Plant JD
Vet Dermatol; 2007 Oct; 18(5):294-300. PubMed ID: 17845616
[TBL] [Abstract][Full Text] [Related]
4. Development of an owner-assessed scale to measure the severity of pruritus in dogs.
Hill PB; Lau P; Rybnicek J
Vet Dermatol; 2007 Oct; 18(5):301-8. PubMed ID: 17845617
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of the Canine Atopic Dermatitis Lesion Index, a scale for the rapid scoring of lesion severity in canine atopic dermatitis.
Plant JD; Gortel K; Kovalik M; Polissar NL; Neradilek MB
Vet Dermatol; 2012 Dec; 23(6):515-e103. PubMed ID: 23140318
[TBL] [Abstract][Full Text] [Related]
6. Validation of CADESI-03, a severity scale for clinical trials enrolling dogs with atopic dermatitis.
Olivry T; Marsella R; Iwasaki T; Mueller R;
Vet Dermatol; 2007 Apr; 18(2):78-86. PubMed ID: 17355421
[TBL] [Abstract][Full Text] [Related]
7. A randomized comparative clinical trial of recombinant canine interferon-gamma (KT-100) in atopic dogs using antihistamine as control.
Iwasaki T; Hasegawa A
Vet Dermatol; 2006 Jun; 17(3):195-200. PubMed ID: 16674735
[TBL] [Abstract][Full Text] [Related]
8. Validation of the Canine Atopic Dermatitis Extent and Severity Index (CADESI)-4, a simplified severity scale for assessing skin lesions of atopic dermatitis in dogs.
Olivry T; Saridomichelakis M; Nuttall T; Bensignor E; Griffin CE; Hill PB;
Vet Dermatol; 2014 Apr; 25(2):77-85, e25. PubMed ID: 24461108
[TBL] [Abstract][Full Text] [Related]
9. Determination of CADESI-03 thresholds for increasing severity levels of canine atopic dermatitis.
Olivry T; Mueller R; Nuttall T; Favrot C; Prélaud P;
Vet Dermatol; 2008 Jun; 19(3):115-9. PubMed ID: 18477326
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of an essential fatty acid-enriched diet in managing canine atopic dermatitis: a randomized, single-blinded, cross-over study.
Bensignor E; Morgan DM; Nuttall T
Vet Dermatol; 2008 Jun; 19(3):156-62. PubMed ID: 18477332
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
Münster M; Hörauf A; Bilzer T
Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
[TBL] [Abstract][Full Text] [Related]
12. Tepoxalin reduces pruritus and modified CADESI-01 scores in dogs with atopic dermatitis: a prospective, randomized, double-blinded, placebo-controlled, cross-over study.
Horvath-Ungerboeck C; Thoday KL; Shaw DJ; van den Broek AH
Vet Dermatol; 2009 Aug; 20(4):233-42. PubMed ID: 19552701
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind, placebo-controlled study to evaluate the effect of EFF1001, an Actinidia arguta (hardy kiwi) preparation, on CADESI score and pruritus in dogs with mild to moderate atopic dermatitis.
Marsella R; Messinger L; Zabel S; Rosychuck R; Griffin C; Cronin PO; Belofsky G; Lindemann J; Stull D
Vet Dermatol; 2010 Feb; 21(1):50-7. PubMed ID: 19843302
[TBL] [Abstract][Full Text] [Related]
14. Use of immunostimulatory liposome-nucleic acid complexes in allergen-specific immunotherapy of dogs with refractory atopic dermatitis - a pilot study.
Mueller RS; Veir J; Fieseler KV; Dow SW
Vet Dermatol; 2005 Feb; 16(1):61-8. PubMed ID: 15725107
[TBL] [Abstract][Full Text] [Related]
15. Prospective open pilot study on the use of ciclosporin for feline allergic skin disease.
Noli C; Scarampella F
J Small Anim Pract; 2006 Aug; 47(8):434-8. PubMed ID: 16911110
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of AHR-13268, an antiallergenic compound, in the management of pruritus caused by atopic disease in dogs.
DeBoer DJ; Moriello KA; Pollet RA
Am J Vet Res; 1992 Apr; 53(4):532-6. PubMed ID: 1350185
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of low dose immunotherapy in the treatment of canine atopic dermatitis: a prospective, double-blinded, clinical study.
Colombo S; Hill PB; Shaw DJ; Thoday KL
Vet Dermatol; 2005 Jun; 16(3):162-70. PubMed ID: 15960629
[TBL] [Abstract][Full Text] [Related]
18. Objective measurement of pruritus in dogs: a preliminary study using activity monitors.
Nuttall T; McEwan N
Vet Dermatol; 2006 Oct; 17(5):348-51. PubMed ID: 16961821
[TBL] [Abstract][Full Text] [Related]
19. The glucocorticoid sparing efficacy of Phytopica in the management of canine atopic dermatitis.
Schmidt V; McEwan N; Volk A; Helps J; Morrell K; Nuttall T
Vet Dermatol; 2010 Feb; 21(1):96-105. PubMed ID: 20187915
[TBL] [Abstract][Full Text] [Related]
20. Application of a scaling model to establish and validate an interval level pain scale for assessment of acute pain in dogs.
Morton CM; Reid J; Scott EM; Holton LL; Nolan AM
Am J Vet Res; 2005 Dec; 66(12):2154-66. PubMed ID: 16379662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
